Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02703272
Title A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: child | adult
Covered Countries USA | NLD | GBR | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Los Angeles California United States Details
Orange California United States Details
Palo Alto California United States Details
Aurora Colorado United States Details
Washington District of Columbia United States Details
Atlanta Georgia United States Details
Baltimore Maryland United States Details
Boston Massachusetts United States Details
New York New York United States Details
Valhalla New York United States Details
Charlotte North Carolina United States Details
Cincinnati Ohio United States Details
Columbus Ohio United States Details
Philadelphia Pennsylvania United States Details
Dallas Texas United States Details
Salt Lake City Utah United States Details
Milwaukee Wisconsin United States Details
Brussel Belgium Details
Leuven Belgium Details
Barretos Brazil Details
Curitiba Brazil Details
Sao Paulo Brazil Details
São Paulo Brazil Details
Plovdiv Bulgaria Details
Sofia Bulgaria Details
Halifax Nova Scotia Canada Details
Toronto Ontario Canada Details
Brno Czechia Details
Praha Czechia Details
Bordeaux France Details
Lille France Details
Lyon France Details
Marseille France Details
Nantes France Details
Toulouse France Details
Vandoeuvre les Nancy France Details
Villejuif France Details
Berlin Germany Details
Freiburg Germany Details
Kiel Germany Details
München Germany Details
Münster Germany Details
Budapest Hungary Details
Debrecen Hungary Details
Seoul Korea, Republic of Details
Rotterdam Netherlands Details
Utrecht Netherlands Details
Krakow Poland Details
Warszawa Poland Details
Wroclaw Poland Details
Bucuresti Romania Details
Cluj-Napoca Romania Details
Oradea Romania Details
Timisoara Romania Details
Ekaterinburg Russian Federation Details
Moscow Russian Federation Details
St. Petersburg Russian Federation Details
Barcelona Spain Details
Esplugues de Llobregat Spain Details
Madrid Spain Details
Valencia Spain Details
Gothenburg Sweden Details
Kaohsiung Taiwan Details
Taipei Taiwan Details
Taoyuan Taiwan Details
Ankara Turkey Details
Izmir Turkey Details
Kiev Ukraine Details
Birmingham United Kingdom Details
Cambridge United Kingdom Details
Leeds United Kingdom Details
Liverpool United Kingdom Details
London United Kingdom Details
Manchester United Kingdom Details
Newcastle United Kingdom Details
Sheffield United Kingdom Details
Surrey United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field